Two best friends in Georgia were both diagnosed with cancer this year. The two boys got to ring the bell signaling the end of ...
A childhood cancer charity is encouraging parents to become more aware of the early signs and symptoms of cancer among ...
The FDA has approved pirtobrutinib for certain adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.The new indication applies to adults who previously have ...
Pirtobrutinib is now FDA-approved for relapsed/refractory CLL/SLL after prior covalent BTK inhibitor therapy, following its 2023 accelerated approval. The BRUIN-CLL-321 trial showed pirtobrutinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback